Skip to Main Content

Skin Diseases, Structural Biology & Crystallography - The Bunick Lab at Yale School of Medicine

October 01, 2025
ID
13473

Transcript

  • 00:05The skin is the largest
  • 00:07organ in the body. And
  • 00:09not only is it a
  • 00:10barrier, but it has a
  • 00:11very active immune system. When
  • 00:13we think of inflammatory
  • 00:14skin disorders, psoriasis, when we
  • 00:16think of atopic dermatitis, they
  • 00:18all have a component of
  • 00:19skin barrier disruption.
  • 00:21And so many of the
  • 00:22diseases in dermatology become a
  • 00:24vicious cycle between skin barrier
  • 00:26disruption and inflammation.
  • 00:28Patients also experience things like
  • 00:30itch,
  • 00:31burning, stinging, and it affects
  • 00:33their quality of life. And
  • 00:35my job as the scientist
  • 00:37is understanding how to break
  • 00:38this loop.
  • 00:46In the big picture, my
  • 00:47laboratory is doing what is
  • 00:48called structural biology. We are
  • 00:50trying to understand the structure
  • 00:52of how proteins,
  • 00:54nucleic acids, and other macromolecules
  • 00:56work in the skin and
  • 00:58how drugs that target different
  • 01:00skin diseases work. And then
  • 01:02in certain genetic diseases where
  • 01:04those proteins
  • 01:05are in error, we want
  • 01:07to understand what has gone
  • 01:08wrong and how can we
  • 01:09fix
  • 01:11it. There's no one else
  • 01:12in dermatology
  • 01:13that is running a primary
  • 01:14NIH funded research lab that's
  • 01:17dedicated to structural biology and
  • 01:19answering those difficult
  • 01:20biochemistry
  • 01:21questions through the approaches of
  • 01:23extra crystallography,
  • 01:25cryo electron microscopy, and if
  • 01:27needed, nuclear magnetic resonance imaging.
  • 01:33So extra crystallography
  • 01:35is a particular technique that
  • 01:37allows you to understand the
  • 01:38atomic level structure
  • 01:40of proteins, nucleic acids, and
  • 01:42their complexes.
  • 01:44What you have to do
  • 01:44in crystallography is take a
  • 01:46very pure protein, for example,
  • 01:48and put it in the
  • 01:49right solution
  • 01:50that allows it to precipitate.
  • 01:52And when it does it
  • 01:53just right, it forms a
  • 01:54crystal. And that crystal is
  • 01:56a perfectly
  • 01:58aligned lattice of lots and
  • 02:00lots of molecules of that
  • 02:01protein of interest. And then
  • 02:03when you hit that crystal
  • 02:04with x rays, that crystal
  • 02:06then diffracts
  • 02:07the light. And then what
  • 02:09we can do is use
  • 02:10mathematical
  • 02:10approaches to take that diffraction
  • 02:12pattern and turn it into
  • 02:14actually a three-dimensional
  • 02:15model
  • 02:16of that protein, and that
  • 02:17allows us to determine the
  • 02:19structure at that atom and
  • 02:20bond level. And then we
  • 02:21can take that information and
  • 02:23ask those critical questions. What
  • 02:25does this tell us about
  • 02:26helping the human patient?
  • 02:33One of the wonderful things
  • 02:34about being a physician scientist
  • 02:36is I get to see
  • 02:37what it's like in the
  • 02:38lab to make a discovery,
  • 02:40but I also get to
  • 02:41talk to patients face to
  • 02:42face. And I really get
  • 02:43an understanding of what matters
  • 02:45to them.
  • 02:46And the advantage of this
  • 02:47is it allows me to
  • 02:48then come back from a
  • 02:50translational perspective and understand
  • 02:52what is going to help
  • 02:54deliver better patient care. This
  • 02:57is also why I really
  • 02:58am excited to be a
  • 02:59part of clinical trials here
  • 03:00in dermatology
  • 03:01at Yale.
  • 03:03I love helping patients. I
  • 03:05love it when patients feel
  • 03:07better and are happier with
  • 03:08themselves.
  • 03:09In the end, all of
  • 03:10what we do, whether it's
  • 03:11the research mission,
  • 03:13the clinical mission, or even
  • 03:14a clinical trial mission, it's
  • 03:16all about advancing patient care,
  • 03:18developing new therapies for rare
  • 03:20genetic skin diseases for which
  • 03:22patients have nothing yet.